Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Prevalence estimates of use of cancer screening tests among American Indian/Alaska Native and non-Hispanic White adults resident in CHSDA counties—Behavioral Risk Factor Surveillance System, 2000–2006a

  NHW Totala AI/AN Totala Northern Plainsb Alaskac Southern Plainsd Pacific Coaste Eastf Southwestg
%h (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Mammography within 2 years, women aged 40+i
  76.0 (75.5–76.5) 68.7 (64.7–72.4) 73.9 (67.8–79.3) 75.9 (69.6–81.2) 71.3 (66.2–76.0) 63.3 (52.3–73.1) 70.7 (59.7–79.7) 65.0 (58.4–71.0)
Papanicolaou (Pap) test within 3 years women without hysterectomyi
  83.7 (83.3–84.1) 79.3 (76.4–82.0) 83.3 (79.1–86.8) 87.5 (84.5–90.1) 77.7 (73.7–81.3) 76.4 (69.1–82.4) 74.9 (64.7–82.9) 80.1 (76.4–83.4)
Prostate specific antigen test within 1 year, men aged 50–75j
  53.0 (52.3–53.6) 44.4 (39.2–49.7) 50.0 (42.4–57.6) 34.8 (27.8–42.5) 45.4 (40.1–50.7) 45.4 (35.2–56.1) 43.4 (34.0–53.4) 41.6 (35.9–47.5)
Fecal occult blood test within 1 year or endoscopy within 5 years, aged 50+j
All 54.3 (53.8–54.8) 40.2 (35.5–45.0) 36.0 (29.1–43.5) 49.4 (42.8–56.1) 42.4 (38.1–46.9) 41.1 (31.5–51.5) 41.3 (32.5–50.7) 33.8 (28.8–39.1)
Male 56.0 (55.2–56.8) 39.6 (32.7–47.0) 26.0 (18.4–35.4) 42.9 (33.6–52.6) 46.4 (39.5–53.5) 45.9 (32.3–60.2) 29.8 (19.9–42.1) 33.6 (26.1–42.0)
Female 53.1 (52.4–53.8) 41.4 (35.9–47.1) 45.2 (36.2–54.6) 55.1 (46.0–63.8) 38.8 (33.6–44.3) 40.0 (27.8–53.6) 53.5 (41.7–64.9) 33.9 (27.6–40.8)

CHSDA indicates Contract Health Service Delivery Areas of the Indian Health Service; NHW, non-Hispanic whites; AI/AN, American Indians/Alaska Natives; 95% CI, 95% confidence interval.

a Data from 33 U.S. states (includes states listed in the footnotes below).
b AI/AN in Indiana, Iowa, Michigan, Minnesota, Montana, Nebraska, North Dakota, South Dakota, Wisconsin, and Wyoming.
c AI/AN in Alaska.
d AI/AN in Kansas, Oklahoma, and Texas.
e AI/AN in California, Idaho, Oregon, and Washington.
f AI/AN in Alabama, Connecticut, Florida, Louisiana, Maine, Massachusetts, Mississippi, New York, North Carolina, Rhode Island, and South Carolina.
g AI/AN in Arizona, Colorado, Nevada, New Mexico, and Utah.
h All prevalence estimates are weighted and age-adjusted to the 2000 US standard population. "Refused" and "don’t know" responses are excluded.
i 2000, 2002, 2004, and 2006 (AI/AN estimates do not include Massachusetts).
j 2001, 2002, 2004, and 2006 (AI/AN estimates do not include Massachusetts).

Download table formatted for print (PDF-36KB)

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #